Skip to main content

ALS Research

Where investment meets impact

Could a keto diet slow the progression of ALS?

Dr. Chantelle Sephton (Université Laval) is researching whether a high-fat, low-carb ketogenic diet can slow ALS progression by restoring mitochondrial function. Preliminary mouse studies show promising results, with potential for future clinical trials.

Read the full story

Approximately 4,000 Canadians are living with amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. Brain Canada funds cutting-edge research that could support better diagnosis and treatment to improve the lives of people living with ALS.

Donate

Our Projects

Brain Canada’s rigorous scientific review process gives donors and partners a trusted mechanism to ensure projects are chosen based on merit, innovation, and potential for impact.

Search the directory

$35,096,718
invested

125
grants awarded

Our Partners

Making a significant difference in the lives of people in Canada doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convenor and facilitator, Brain Canada works with partners from coast to coast to drive innovative brain research. Some of our partners in supporting ALS research include:

See all our partners